Medicap Pharmacy is a retail pharmacy franchise with no initial franchise fee and flexible royalty structure (3% of gross sales OR $599/month fixed fee). The system has been declining from 67 units in 2023 to 59 units currently. The franchise requires substantial investment ($513k-$896k) primarily for inventory, equipment, and working capital. No exclusive territory is granted and franchisors can compete directly. The contract offers automatic renewal rights and reasonable termination protections. However, the lack of training programs and declining unit count raise concerns about ongoing support and system viability.
Generated from 2025 Franchise Disclosure Document
AI-generated from FDD analysis — use as a checklist with your attorney
Total startup costs, working capital, and financial requirements
Training, marketing support, technology, and operational assistance
Royalty, marketing, technology, and other ongoing fees
Revenue data, P&L estimates, and financial projections
Lawsuits, disputes, and legal risk assessment
Territory rights, term length, non-compete, and transfer rules
82 legal provisions scored on a franchisee-friendliness scale
Unit growth trends, exit rates, and system trajectory
Similar to Medicap Pharmacy in category and investment range